Shares of Eli Lilly & Co. LLY inched 0.50% higher to $781.98 Friday, on what proved to be an all-around positive trading ...

Eli Lilly is joining in a lawsuit filed by the Outsourcing Facilities against the FDA, aiming to reverse the FDA's October 2024 determination that the shortage has been resolved, which would allow ...

The state has spent more than $690 million so far establishing the LEAP Research and Innovation District. Outgoing economic ...

Eli Lilly is seeking to end a lawsuit filed by a pharmacy trade group against the Food and Drug Administration (FDA) by ...

The FDA has approved Lilly's Zepbound, a glp-1 agonist, for the treatment of sleep apnea, which affects 25 million Americans ...

The scholarship will pay for 4 years of tuition, fees and books at an Indiana public or private nonprofit college or ...

IU Indianapolis hosts the Youngstown State Penguins after Sean Craig scored 22 points in IU Indianapolis' 88-81 loss to the Milwaukee Panthers.

MORF-057 is under clinical development by Eli Lilly and Co and currently in Phase II for Crohn's Disease (Regional Enteritis).

CFTX-1554 is under clinical development by Eli Lilly and Co and currently in Phase I for Peripheral Neuropathic Pain.

It’s been another busy year in Indiana health care and life sciences, with headlines nearly every week announcing another ...

A sign with the company logo stands in front of the Eli Lilly and Company headquarters campus in Indianapolis, Indiana, on March 17, 2024. New study data has solidified the club's position Eli Lillyis ...

The Carroll County Community Foundation is pleased to announce the recipient of the 2025 Lilly Endowment Community ...